Neuromyelitis optica spectrum disorder following COVID-19 infection with increase in pre-existing anti-aquaporin-4 antibodies
- 22 January 2022
- journal article
- letter
- Published by Springer Science and Business Media LLC in Zeitschrift für Neurologie
- Vol. 269 (6), 2850-2853
- https://doi.org/10.1007/s00415-022-10972-9
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Association of CNS demyelination and COVID-19 infection: an updated systematic reviewZeitschrift für Neurologie, 2021
- Proinflammatory IgG Fc structures in patients with severe COVID-19Nature Immunology, 2020
- Neuromyelitis opticaNature Reviews Disease Primers, 2020
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- Nervous system involvement after infection with COVID-19 and other coronavirusesBrain, Behavior, and Immunity, 2020
- Impact of autoantibody glycosylation in autoimmune diseasesAutoimmunity Reviews, 2014
- Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis OpticaJournal of Immunology Research, 2013
- Strategy for anti-aquaporin-4 auto-antibody identification and quantification using a new cell-based assayClinical Immunology, 2011
- A serological analysis of viral and bacterial infections associated with neuromyelitis opticaJournal of the Neurological Sciences, 2011
- IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channelThe Journal of Experimental Medicine, 2005